HDAC9 and cancer: Some studies have also shown synergistic anti-cancer effects between TRAIL and HDAC inhibitors.35, 36, 37 Western blot analysis shows that the HDAC inhibitor vorinostat alters death receptor expression in HepG2 cells (Figure 3A).